Display options
Share it on

Can Commun Dis Rep. 2015 Feb 20;41:18-23. doi: 10.14745/ccdr.v41is1a04. eCollection 2015 Feb 20.

Canadian vaccine research networks: Vaccine safety resources for Canada.

Canada communicable disease report = Releve des maladies transmissibles au Canada

J McCarthy, S A Halperin, J A Bettinger, J M Langley, N S Crowcroft, S Deeks, J C Kwong, G De Serres, K Top, S McNeil, D W Scheifele,

Affiliations

  1. Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Capital Health, Halifax, NS.
  2. Department of Pediatrics, Dalhousie University, Halifax, NS.
  3. Department of Pediatrics and the Child & Family Research Institute, University of British Columbia, Vancouver, BC.
  4. Vaccine Evaluation Center, BC Children's Hospital and the University of British Columbia, Vancouver, BC.
  5. Public Health Ontario, Toronto, ON.
  6. Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
  7. Institute for Clinical Evaluative Sciences, Toronto, ON.
  8. Department of Medicine, Laval University, Québec, QC.
  9. Institut national de santé publique du Québec, Montréal, QC.
  10. Department of Medicine, Dalhousie University, Halifax, NS.

PMID: 29769957 PMCID: PMC5868603 DOI: 10.14745/ccdr.v41is1a04

Abstract

The Public Health Agency of Canada / Canadian Institutes of Health Research Influenza Research Network (PCIRN), established in 2009 to undertake evaluative research to inform public health decision making in Canada, is now being replaced by the Canadian Immunization Research Network (CIRN), which will retain the mandate of PCIRN but expand it to all vaccines including influenza vaccine. CIRN is organized as a network of networks focusing on undertaking research in the areas of vaccine safety, adverse events following immunization (AEFIs), vaccine hesitancy, vaccine effectiveness, and vaccine coverage. CIRN's networks include: a clinical trial network; a laboratory network; a modelling and economics network; a network of social science and humanities researchers; a vaccine safety surveillance network; a hospital-based surveillance network; a clinic network to evaluate serious AEFIs; and a network that links vaccine research capacity in provincial health agencies and departments. PCIRN has contributed to Canada's vaccine safety surveillance system and has facilitated the translation of safety research into policy. Vaccine safety surveillance and research will remain a focus of the newly formed Canadian Immunization Research Network.

Conflict of interest statement

Conflict of interest: Scott A. Halperin reports grants from the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada during the conduct of the study and grants from mul

References

  1. Vaccine. 2012 Jul 6;30(32):4728-32 - PubMed
  2. Hum Vaccin Immunother. 2013 Jan;9(1):136-43 - PubMed
  3. Pediatrics. 2011 May;127 Suppl 1:S45-53 - PubMed
  4. Pediatr Infect Dis J. 2014 Oct;33(10):1060-4 - PubMed
  5. HIV Clin Trials. 2012 Jan-Feb;13(1):23-32 - PubMed
  6. J Allergy Clin Immunol. 2012 Nov;130(5):1213-1216.e1 - PubMed
  7. CMAJ. 2011 Sep 20;183(13):E1033-7 - PubMed
  8. PLoS One. 2012;7(7):e38563 - PubMed
  9. J Allergy Clin Immunol. 2010 Aug;126(2):317-23 - PubMed
  10. Vaccine. 2012 May 14;30(23):3389-94 - PubMed

Publication Types